Lv11
20 积分 2022-10-10 加入
Next generation of anti-PD-L1 Atezolizumab with enhanced anti-tumor efficacy in vivo
9小时前
已完结
Integrating computational simulation and high-throughput screening for the development of robust ultra-high concentration formulation of IgG1 antibody
9小时前
已完结
Enhancing Bioavailability of Ultra‐High Concentration Antibody Formulations Using Ionic Liquids
1个月前
已完结
Derivation of the toxicological threshold of silicon element in the extractables and leachables from the pharmaceutical packaging and process components
3个月前
已完结
Stability study of full-length antibody (anti-TNF alpha) loaded PLGA microspheres
3个月前
已完结
PLGA/alginate composite microspheres for hydrophilic protein delivery
3个月前
已完结
Challenges and developments in the manufacturing of high-concentration biotherapeutic monoclonal antibodies
5个月前
已完结
Protein stability and viscosity in molecularly crowded high-concentration biologics
5个月前
已完结
High concentration subcutaneous biological drug products: challenges and advancements
5个月前
已完结
Current and emerging strategies for subcutaneous delivery of high-concentration and high-dose antibody therapeutics
5个月前
已完结
皖公网安备34019202002308
